Literature DB >> 6263446

Detection of true pathologic stage I lung cancer in a screening program and the effect on survival.

M R Melamed, B J Flehinger, M B Zaman, R T Heelan, E T Hallerman, N Martini.   

Abstract

One-hundred-sixty-nine lung cancers have occurred to date among 10,040 cigarette smoking men who participated in the New York Lung Cancer Detection Program. Almost 40% of the cases, 65, were still Stage I when their disease was diagnosed; 62 had thoracotomy and resection, and in 57, mediastinal node dissection confirmed that the mediastinum was free of metastases ("true pathologic" Stage I). Fifty-four of the 62 (87%) are still alive at this time, while only 15 of 104 (14%) of those with Stage II and III lung cancers are alive. Only two patients of the 62 in Stage I who were treated by resection died of lung cancer, both with T2 tumors. Two others are alive with metastases, one died postoperatively, and five died of other causes without evidence of lung cancer. The estimated probability of survival for true Stage I lung cancer is over 90% at five years, and close to 40% of all lung cancers can be detected in this favorable stage by present radiologic and cytologic screening techniques.

Entities:  

Mesh:

Year:  1981        PMID: 6263446     DOI: 10.1002/1097-0142(19810301)47:5+<1182::aid-cncr2820471322>3.0.co;2-4

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  10 in total

1.  Chest diseases-important advances in clinical medicine: bronchoscopy and lasers.

Authors:  O J Balchum
Journal:  West J Med       Date:  1984-01

2.  Cytologic findings in stage I adenocarcinoma of the lung: implications for the detection of early lung cancer.

Authors:  J Bjornsson; J R Goellner; D E Williams; M V Scheiber
Journal:  J Cancer Res Clin Oncol       Date:  1986       Impact factor: 4.553

Review 3.  Recent advances in respiratory medicine.

Authors:  D C Flenley
Journal:  Postgrad Med J       Date:  1983-01       Impact factor: 2.401

4.  Resectability of lung cancer and survival in the New York Lung Cancer Detection Program.

Authors:  H J Flehinger; M R Melamed; M B Zaman; R T Heelan; W Perchick; N Martini
Journal:  World J Surg       Date:  1981-09       Impact factor: 3.352

5.  Solitary and multiple resected adenocarcinomas after CT screening for lung cancer: histopathologic features and their prognostic implications.

Authors:  Madeline Vazquez; Darryl Carter; Elizabeth Brambilla; Adi Gazdar; Masayuki Noguchi; William D Travis; Yao Huang; Lijuan Zhang; Rowena Yip; David F Yankelevitz; Claudia I Henschke
Journal:  Lung Cancer       Date:  2008-10-31       Impact factor: 5.705

6.  Primary care radiography in the early diagnosis of lung cancer.

Authors:  Trevor K Rogers
Journal:  Cancer Imaging       Date:  2010-03-16       Impact factor: 3.909

7.  Screening for occult lung cancer.

Authors:  T H Barclay; J H MacIntosh
Journal:  Can Med Assoc J       Date:  1983-04-15       Impact factor: 8.262

Review 8.  Update in cancer chemotherapy, Part III: Lung cancer, Part 1.

Authors:  J C Wright
Journal:  J Natl Med Assoc       Date:  1985-10       Impact factor: 1.798

Review 9.  Known occupational carcinogens and their significance.

Authors:  P Ernst; G Thériault
Journal:  Can Med Assoc J       Date:  1984-04-01       Impact factor: 8.262

10.  Screening for lung cancer.

Authors:  D Carter
Journal:  Yale J Biol Med       Date:  1981 Sep-Oct
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.